Xvivo Perfusion AB (XVIVO) — Strategic Asset Allocation Index
Xvivo Perfusion AB (XVIVO) has a Strategic Asset Allocation Index of 10.1% as of December 2025. Strategic assets (PP&E of Skr213.88 Million plus long-term investments of Skr-) total Skr213.88 Million, measured against net assets of Skr2.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Xvivo Perfusion AB Strategic Asset Allocation Index (2011–2025)
This chart shows how Xvivo Perfusion AB's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2025. As of December 2025, the index stands at 10.1%, representing strategic assets of Skr213.88 Million against net assets of Skr2.11 Billion SEK. Explore cash flow conversion of Xvivo Perfusion AB to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Xvivo Perfusion AB (2011–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Xvivo Perfusion AB from 2011 to 2025, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see XVIVO market cap.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.1% | Skr213.88 Million | Skr213.88 Million | Skr- | Skr2.11 Billion | ▲ +3.2 pp |
| 2024 | 6.9% | Skr149.04 Million | Skr149.04 Million | Skr- | Skr2.16 Billion | ▲ +1.9 pp |
| 2023 | 5.0% | Skr97.55 Million | Skr97.55 Million | Skr- | Skr1.95 Billion | ▲ +1.7 pp |
| 2022 | 3.3% | Skr47.58 Million | Skr47.58 Million | Skr- | Skr1.43 Billion | ▲ +1.3 pp |
| 2021 | 2.0% | Skr26.30 Million | Skr26.30 Million | Skr- | Skr1.29 Billion | ▼ -0.1 pp |
| 2020 | 2.1% | Skr21.33 Million | Skr21.33 Million | Skr- | Skr1.01 Billion | ▼ -2.0 pp |
| 2019 | 4.1% | Skr23.78 Million | Skr23.55 Million | Skr223.00K | Skr577.52 Million | ▲ +1.2 pp |
| 2018 | 2.9% | Skr15.69 Million | Skr15.62 Million | Skr71.00K | Skr540.48 Million | ▼ -0.3 pp |
| 2017 | 3.2% | Skr16.35 Million | Skr16.28 Million | Skr71.00K | Skr504.33 Million | ▼ -1.6 pp |
| 2016 | 4.8% | Skr15.17 Million | Skr15.17 Million | Skr- | Skr316.41 Million | ▲ +0.9 pp |
| 2015 | 3.9% | Skr7.12 Million | Skr7.12 Million | Skr- | Skr184.87 Million | ▲ +3.2 pp |
| 2014 | 0.6% | Skr1.12 Million | Skr1.12 Million | Skr- | Skr176.18 Million | ▼ -0.3 pp |
| 2013 | 0.9% | Skr917.00K | Skr917.00K | Skr- | Skr96.64 Million | ▲ +0.2 pp |
| 2011 | 0.8% | Skr92.00K | Skr92.00K | Skr- | Skr11.91 Million | — |